--

Dr. Nicola Dallas is a Consultant Clinical Oncologist for NHS patients at the Royal Berkshire Hospital in Reading and Wexham Park Hospital in Slough and has been a partner in the Berkshire Oncology Partnership since 2012. She also has private practice in the area.

Dr. Dallas graduated from the University of Birmingham Medical School in 1998 and became a member of the Royal College of Physicians in 2001. She completed her specialist oncology training in Oxford becoming a Fellow of the Royal College of Radiologists in 2007. She was appointed as a Consultant Clinical Oncologist at the Berkshire Cancer Centre, Royal Berkshire Hospital in Reading in 2011.

Dr. Dallas specialises in the treatment of prostate, bladder, kidney and testicular cancers, head and neck and thyroid cancers. She has a particular interest in technical radiotherapy techniques including IMRT, dynamic arc IMRT and IGRT; the most cutting edge therapies, allowing her patients the best possible outcomes.

In addition to her practice, Dr. Dallas is involved in medical research and is the principle investigator for a number of phase 3 clinical trials in urological and head and neck cancers.

At the Berkshire Cancer Centre she is the Clinical Governance and Audit Lead as well as an educational and clinical supervisor to specialist oncology trainees.

• Radiotherapy
• IMRT
• IGRT
• Stereotactic radiotherapy
• SABR
• SBRT
• MR Linac
• Hormone therapy
• Chemotherapy
• Immunotherapy
• Biological therapies
• Therapeutic Radioisotopes

• Prostate cancer
• Bladder cancer
• Kidney cancer
• Testicular cancer
• Germ cell tumours
• Head & neck cancer
• Oropharyngeal cancer
• Tonsil cancer
• Tongue cancer
• Nasopharyngeal cancer
• Salivary gland tumours
• Thyroid cancer